To address the problem, researchers suggested banning commission payments to drug reps for marketing opioids, stiffer monitoring of opioid advertisements and use of real-time electronic prescription databases to prevent overlapping prescriptions.
Researchers also suggested educational outreach programs to help physicians improve opioid prescribing and more research to guide practice. They said evidence on use of opioids to control chronic pain is very limited.
Related Articles on Opioids for Pain Management:
Global Pain Medication Sales Rise 8.9% Since 2005
Half of Patients Prescribed Opioids Still Taking Them Five Years Later
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
